TCT 2020: New Clinical Data

Protected PCI in COVID-19 Era: The Rise in Importance of Complete Revascularization

Complete revascularization has become more important in the high-risk and complex patient population, exacerbated by the COVID-19 pandemic. Learn more about the benefits of complete revascularization and insights from large multi-center studies around the world on contemporary practice of high-risk PCI with Impella support.


Protected PCI in COVID-19 Era: The Rise in Importance of Complete Revascularization
Cindy Grines, MD


Rapid and Safe Adoption of the New Single Access Technique
Duane Pinto, MD, MPH


Clinical Relevance of Revascularization Extent in Protected PCI: Insight From Italian Studies
Francesco Burzotta, MD


Contemporary Practices of HR-PCI With Percutaneous MCS: Results From PROTECT III, the Largest Prospective Multi-Center Single-Arm Study
Jeffrey Moses, MD

Achieving >70% AMI-CS Survival: Best Practices From Around the World

Achieving >70% survival in AMI-CS is reproducible with best practice protocols. This symposium will provide the key learnings and the supporting clinical evidence of the best practices from USA, Japan and Europe.


Achieving >70% AMI-CS Survival: Insight From National Cardiogenic Shock Initiative
William O'Neill, MD


Closing Summation, RECOVER III, and Intro to RECOVER IV
William O'Neill, MD


Efficacy and Safety of ALL Impella Use in Japanese Patients With Drug-Resistant Acute HF: Insight From Japan J-PVAD Study
Junya Ako, MD


Importance of Timing and Impact of Extensive Revascularization on Long-term Survival in Cardiogenic Shock: Insights From European Multicenter Studies
Giuseppe Tarantini, MD, PhD

Restore EF Study Demonstrates Impella-Supported High-Risk PCI Improves Left Ventricular Ejection Fraction


Intermediate-Term Left Ventricular Function Following Non-Emergent Impella Protected PCI: Restore EF Study
Mitul Patel, MD

Coming soon:

A Propensity-matched Analysis of Impella Support in Patients Undergoing High Risk PCI from a Large-scale Claims Database: Influence of Analytic Methodology on Clinical Outcomes
Alexandra Lansky, MD, FACC, FAHA, FSCAI, FESC